Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
3.060
-0.080 (-2.55%)
Nov 2, 2026, 4:00 PM EST - Market closed
Lexeo Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
63
Market Cap
251.05M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 654.00K | -1.00M | -60.53% |
| Dec 31, 2021 | 1.66M | 1.14M | 219.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bicycle Therapeutics | 83.53M |
| Clinuvel Pharmaceuticals | 65.05M |
| Q32 Bio | 53.74M |
| Abeona Therapeutics | 25.52M |
| Lineage Cell Therapeutics | 13.08M |
| Fate Therapeutics | 6.49M |
| Ocugen | 4.58M |
| Lyell Immunopharma | 27.00K |
LXEO News
- 10 hours ago - Lexeo Therapeutics to Present Multiple Oral and Poster Presentations at Key Scientific Conferences in November - GlobeNewsWire
- 4 days ago - Lexeo Therapeutics Registration statement: Registration filing - Filings
- 4 days ago - Lexeo Therapeutics files $300M mixed securities shelf - TheFly
- 12 days ago - Lexeo Therapeutics Transcript: Investor update - Transcripts
- 13 days ago - Lexeo Therapeutics Transcript: Chardan's 10th Annual Healthcare Conference - Transcripts
- 14 days ago - Lexeo Therapeutics to Host Educational Event Focused on Clinical Endpoints and Outcome Measures in PKP2-ACM - GlobeNewsWire
- 25 days ago - Lexeo Therapeutics to Participate in the Chardan Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Lexeo Therapeutics Announces Oral Presentation of LX2006 at the International Congress of Parkinson's Disease and Movement Disorders 2026 (MDS) - GlobeNewsWire